Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • Influenza Hemagglutinin (HA) Peptide: Precision Epitope T...

    2026-03-25

    Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tag for Molecular Biology

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid tag derived from influenza virus hemagglutinin, used extensively for protein tagging and detection in molecular biology. This peptide demonstrates high chemical purity (>98%, confirmed by HPLC and MS) and exceptional solubility in water (≥46.2 mg/mL), DMSO (≥55.1 mg/mL), and ethanol (≥100.4 mg/mL), facilitating diverse biochemical workflows (APExBIO). The HA tag enables competitive elution in immunoprecipitation assays using anti-HA antibodies, supporting highly specific and reproducible protein purification (Dong et al., 2025). Proper storage at -20°C (desiccated) preserves peptide activity and stability for research applications. The HA epitope is integral to studies of protein-protein interactions, cell signaling, and translational cancer biology (Flag-Peptide.com).

    Biological Rationale

    The influenza hemagglutinin (HA) tag is a minimal, linear epitope recognized by high-affinity anti-HA monoclonal antibodies. The nine-residue peptide (YPYDVPDYA) is derived from the viral hemagglutinin protein, conferring low immunogenicity and minimal structural interference with fusion partners (APExBIO). The HA tag is used to label recombinant proteins, enabling detection, purification, and quantitation in cell lysates and tissue samples. HA tagging empowers the study of protein localization, protein-protein interactions, and post-translational modifications under physiologically relevant conditions. This is particularly relevant for mechanistic studies in cancer biology, where mapping protein complex dynamics is critical (Dong et al., 2025).

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The HA peptide functions as an epitope tag by competitively binding to anti-HA antibodies. In immunoprecipitation (IP) assays, HA-tagged proteins are captured via anti-HA antibody-conjugated beads. The introduction of free HA peptide (e.g., the A6004 reagent from APExBIO) displaces the HA-tagged target from the antibody through competitive inhibition, enabling gentle, specific elution of the protein complex (Tiloronesmallmol.com). This approach circumvents harsh elution conditions that can disrupt protein conformation or interaction partners, preserving native complexes for downstream analysis. The short linear sequence ensures that the peptide is accessible to antibody binding, regardless of the fusion protein's tertiary structure. The HA peptide's high solubility in standard laboratory solvents (water, DMSO, ethanol) facilitates its use in a broad range of applications and buffer systems (APExBIO).

    Evidence & Benchmarks

    • HA peptide (YPYDVPDYA) enables efficient competitive elution of HA-tagged proteins from anti-HA antibody beads, preserving protein-protein interactions (Dong et al., 2025, https://doi.org/10.1002/advs.202504704).
    • High chemical purity of the A6004 HA peptide (>98%, confirmed by HPLC and MS) ensures reproducibility and minimal background in immunoassays (APExBIO).
    • Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water, supporting high-concentration workflows (APExBIO).
    • In vivo screening studies using HA-tagged constructs elucidate E3 ligase function in cancer metastasis, validating the tag's utility for mechanistic cell signaling research (Dong et al., 2025, https://doi.org/10.1002/advs.202504704).
    • Multiple internal studies confirm the HA tag's compatibility with Western blotting, immunofluorescence, and co-immunoprecipitation, outperforming alternative tags for sensitivity and specificity (Flag-Peptide.com).

    Applications, Limits & Misconceptions

    The Influenza Hemagglutinin (HA) Peptide has broad applications in molecular biology, cell biology, and translational research:

    • Epitope tagging of recombinant proteins for detection and quantitation by anti-HA antibody-based assays.
    • Gentle, specific elution of HA-tagged complexes in co-immunoprecipitation and protein-protein interaction studies.
    • Workflow optimization in proteomics, including tandem affinity purification and mass spectrometry-compatible protocols.
    • Functional studies in oncology, e.g., mapping E3 ligase–substrate interactions in metastatic signaling networks (Dong et al., 2025).

    Common Pitfalls or Misconceptions

    • Not a universal tag: The HA tag may not be suitable when endogenous HA cross-reactivity occurs in certain host systems (e.g., avian cells).
    • Elution efficiency is concentration dependent: Insufficient HA peptide concentration may fail to fully displace tightly bound HA-tagged proteins from anti-HA beads.
    • Not for long-term solution storage: HA peptide solutions can degrade; always prepare fresh solutions or store lyophilized at -20°C for optimal stability (APExBIO).
    • Does not provide structural information: The tag is for detection/purification; it does not directly reveal protein structure or function.
    • Sequence context matters: Tag accessibility can be impaired if the fusion site is conformationally buried or masked by post-translational modifications.

    This article extends the practical insights offered by "Optimizing Protein Assays with Influenza Hemagglutinin (HA) Peptide" by systematically benchmarking purity, solubility, and application limits in translational workflows. For a forward-looking perspective on cancer cell signaling applications, see "Leveraging the Influenza Hemagglutinin (HA) Peptide Tag", which this article updates with new mechanistic and storage guidelines.

    Workflow Integration & Parameters

    To maximize the performance of the Influenza Hemagglutinin (HA) Peptide (A6004), follow these workflow parameters:

    • Reconstitution: Dissolve lyophilized HA peptide in water, DMSO, or ethanol to achieve the desired working concentration; typical stock: 1–10 mM.
    • Storage: Store lyophilized peptide desiccated at -20°C. Avoid repeated freeze-thaw cycles. Do not store peptide solutions long-term; prepare fresh aliquots as needed (APExBIO).
    • Immunoprecipitation: Add HA peptide at concentrations of 0.1–1 mg/mL to elute HA-tagged proteins from anti-HA antibody-conjugated beads. Optimize for target protein abundance and binding affinity.
    • Detection: Compatible with anti-HA monoclonal antibodies (e.g., clone 12CA5 or 3F10) in Western blot, immunofluorescence, and flow cytometry protocols.
    • Compatibility: The tag is compatible with mammalian and insect expression systems; verify absence of endogenous HA-like sequences in the host proteome for optimal specificity.

    For workflow troubleshooting and advanced benchmarking against alternative tags, the article "Influenza Hemagglutinin (HA) Peptide: Advanced Tagging for Protein Research" provides comparative performance data, which this review contextualizes with APExBIO's latest product specifications.

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide remains a gold-standard tag for protein detection, purification, and mechanistic elucidation of protein complexes. Its high purity, solubility, and competitive binding properties support robust, reproducible workflows across molecular and cell biology. Ongoing innovations in antibody engineering and peptide chemistry promise to further enhance sensitivity and specificity. With proven utility in translational oncology and cell signaling research, the HA tag—especially as supplied by APExBIO—is poised to catalyze advances in systems biology and therapeutic development (Dong et al., 2025). For detailed protocols and product ordering, visit the Influenza Hemagglutinin (HA) Peptide product page.